[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fbA-GEOmizrqetylX9wStKS_Sq_ioSRBCfU0GWSgxLr0":8,"$fF_H_ppfTBeXHcbaUSxJ7HPZkfFtYJAX4LuGQ8n19ITE":55,"$ft8Al3HphK_Hbl6ky5qPi_fJy91QYepPxHj4S3rHj_K4":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},67587,867180,[],"https://ystcdn.venuertc.com/medical/ystApp/dQ4Pxlwso3rc1NhluBbxmQ6HzjnaGqJP.png","王志刚","山西省汾阳医院","妇科","主治医师",23,0,"子宫内膜癌分期2——药品使用实用指南","","https://ystcdn.venuertc.com/venue/AI/f7a4559c-b9e0-42fd-8caa-464209ab0f29.jpg","\u003Cdiv id=\"material_title\" class=\"eknow-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">子宫内膜癌分期2——药品使用实用指南\u003C/h2>\n\u003C/div>\n\n\u003Cdiv class=\"eknow-intro eknow-bg-light\">\n  \u003Cp>说起来，子宫内膜癌药物治疗涉及多种方案，其中\u003Cem>化疗药物、靶向药物和免疫制剂\u003C/em>运用最广。每一类药品都有独特机制和使用细节。本文将结合实际案例，帮你彻底搞清这些药品的关键用法，包括服用时间、剂型特征、相互作用、副作用、特殊人群用药和储存要求。全篇包含 \u003Cstrong>7大要点\u003C/strong>，一次看全，安全用药更安心。📚\u003C/p>\n\u003C/div>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 标准用药时间与具体服用方式 \u003Cspan class=\"eknow-bg-header\">🌱\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cp>\n      大多数子宫内膜癌分期2药品以口服片剂或注射形式为主：\u003Cbr>\n      \u003Cstrong>化疗药物\u003C/strong>（如紫杉醇、铂类）一般按疗程静脉滴注，提前预约，治疗当天定时完成。\u003Cbr>\n      \u003Cstrong>靶向药物\u003C/strong>（如PARP抑制剂、VEGF抑制剂）：通常每日口服，具体早晚时间需遵医嘱，不随餐服用时要用足量清水吞服。\u003Cbr>\n      \u003Cstrong>免疫治疗制剂\u003C/strong>多由专业医师按周期注射。\u003Cbr>\n      正确做法：口服药务必整片吞服，不可研碎或嚼服，注射药要在专业操作下完成。漏服应尽快补服一次，但绝不连服两倍剂量。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 剂型特点与服用技巧 \u003Cspan class=\"eknow-bg-header\">🔬\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cp>\n      \u003Cspan class=\"eknow-highlight\">药品剂型种类\u003C/span>主要包括：\u003Cbr>\n      \u003Cstrong>片剂\u003C/strong>：便于携带，需足量水送服，不宜掰碎，避免影响药效。\u003Cbr>\n      \u003Cstrong>注射液\u003C/strong>：化疗和免疫药通常用静脉注射。必须由专业护士在无菌环境下给药。\u003Cbr>\n      \u003Cstrong>肠溶片/缓释剂型\u003C/strong>：不可碾碎或嚼服，否则会导致药物过量释放或药效变差。\u003Cbr>\n      正确做法：遇到吞咽困难时，建议请医生调整为适宜剂型，避免自行掰碎药片。注射药品如出现浑浊、悬浮、沉淀要及时更换，切忌使用。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药物作用机制简析 \u003Cspan class=\"eknow-bg-header\">🧪\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cp>\n      \u003Cstrong>化疗药物\u003C/strong>（如紫杉醇、顺铂）：通过阻止细胞分裂实现抗肿瘤作用。\u003Cbr>\n      \u003Cstrong>靶向药物\u003C/strong>（如PARP抑制剂、贝伐珠单抗）：以选择性阻断肿瘤细胞特定路径为主，减少对正常细胞影响。\u003Cbr>\n      \u003Cstrong>免疫药物\u003C/strong>（如PD-1抑制剂）：激活自身体防御系统，识别并清除异常细胞。\u003Cbr>\n      数据表明，靶向药物联合治疗的\u003Cem>总缓解率\u003C/em>可达40%-60%，对分期2患者有较好效果。（参见 Monk, B.J., et al., \"Role of Targeted Therapies in Endometrial Cancer,\" Gynecologic Oncology, 2016）\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 典型药物相互作用和影响 \u003Cspan class=\"eknow-bg-header\">💊\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cp>\n      \u003Cstrong>化疗与辅助药物\u003C/strong>：化疗期间如同时服用降糖药、抗凝药（如利伐沙班），有增强骨髓抑制及出血风险，必须监控实验室指标并调整剂量。\u003Cbr>\n      \u003Cstrong>靶向、免疫药品\u003C/strong>：同时使用胺碘酮、氟喹诺酮类等易影响药物代谢，增加心律异常风险。\u003Cbr>\n      \u003Cstrong>中成药辅助\u003C/strong>：部分中药存在与抗肿瘤药品相互作用，可能改变药效或毒副作用。\u003Cbr>\n      正确做法：如需联合服药，先咨询专业医生，每种药品间隔时间应不少于1小时，并避免擅自加减药或同步用药。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 特殊人群用药调整和注意事项 \u003Cspan class=\"eknow-bg-header\">👩‍⚕️\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cp>\n      老年患者、糖尿病患者以及有肾、肝功能减退者用药时要格外注意：\u003Cbr>\n      \u003Cstrong>老年人\u003C/strong>：需根据肝肾功能适度下调化疗剂量，避免骨髓抑制和肝肾损伤。实际案例：有位58岁患者化疗期间调整剂量后骨髓抑制显著降低，避免了严重副作用。\u003Cbr>\n      \u003Cstrong>糖尿病患者\u003C/strong>：部分辅助药物如胰岛素、口服降糖药需和化疗药间隔服用，减轻低血糖风险。\u003Cbr>\n      \u003Cstrong>妊娠和哺乳期妇女\u003C/strong>：不推荐使用绝大部分化疗及靶向药物，必要时严格医生监控。\u003Cbr>\n      正确做法：特殊人群必须定期检测肝肾功能、血常规，出现数据异常及时就医处理。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 药品常见副作用与处理方法 \u003Cspan class=\"eknow-bg-header\">⚠️\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cp>\n      \u003Cstrong>化疗药物\u003C/strong>：常见副作用如恶心、骨髓抑制、脱发。骨髓抑制可导致白细胞减少，感染风险上升。处理办法：发现持续发热、出血应立即联系医生。\u003Cbr>\n      \u003Cstrong>靶向药物\u003C/strong>：高血压、蛋白尿、口腔黏膜损伤较多见。如出现水肿或口腔溃疡，建议调整剂量或暂停用药。免疫药物则偶见皮疹、疲劳等反应。\u003Cbr>\n      数据显示，紫杉醇联用顺铂化疗时，≥50%患者出现恶心或轻度肝功能异常。（参见 Colombo, N., et al., \"Chemotherapy in Endometrial Cancer,\" Annals of Oncology, 2019）\u003Cbr>\n      正确做法：所有副作用要记下发生时间、特点，及时报告医生。不要自行停药或加用药物。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存条件与有效期管理 \u003Cspan class=\"eknow-bg-header\">🔒\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cp>\n      化疗、靶向药和免疫药品均应常温（15-25℃）、避光干燥处保存。部分药品（如注射用药）需冷藏，避免反复冻融。\u003Cbr>\n      药品开封后注明剩余有效天数：片剂通常1个月内用完，注射制剂当天用完。超期药品须按药品垃圾规范丢弃。\u003Cbr>\n      正确做法：每次取药后及时装回药盒，避免高温潮湿。药品如变色、变味不要服用。药品过期坚决不用。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服及过量的应急处理方法 \u003Cspan class=\"eknow-bg-header\">⏱️\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cp>\n      \u003Cstrong>漏服\u003C/strong>：发现后尽快补服一次，不用双倍剂量，下个服药周期按原计划执行。\u003Cbr>\n      \u003Cstrong>过量服用\u003C/strong>：可能导致严重副作用（如恶心、免疫紊乱、出血等）。紧急处理方法：立刻停用药品并保留包装，前往医院就诊，便于医生判断处置。\u003Cbr>\n      正确做法：用药期间固定时间自测药量，如发现多服漏服均记下时间，便于医生准确处理。不要自行采取催吐、补药等措施。\n    \u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 真实用药案例分享 \u003Cspan class=\"eknow-bg-header\">💡\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cul>\n      \u003Cli>\n        临床一例58岁女性患者分期2内膜癌，使用紫杉醇-顺铂联合化疗，定时调整剂量，骨髓抑制风险降低，未发生严重副反应。\n      \u003C/li>\n      \u003Cli>\n        同一患者后期加入利伐沙班辅助抗凝，实验室指标正常，未见明显药物相互作用，体现多药联合安全用药的重要性。\n      \u003C/li>\n      \u003Cli>\n        化疗结束后，应用口服靶向药维持治疗，由于用药期间定期检测肝肾功能，未出现不良反应。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>以上案例说明：合理调整剂量、提前防范副作用、重视药物联合风险，能大幅降低用药风险，提高治疗效果。\u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"eknow-section\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 关键数据与权威文献 \u003Cspan class=\"eknow-bg-header\">📑\u003C/span>\u003C/h2>\n  \u003Cdiv class=\"eknow-bg-block\">\n    \u003Cp>\n      临床研究显示，分期2内膜癌多药联合治疗的\u003Cem>总缓解率\u003C/em>超过了传统单药治疗。副作用发生率可控，安全性有保障：\u003Cbr>\n      \u003C/p>\u003Cul>\n        \u003Cli>紫杉醇-顺铂化疗方案中骨髓抑制发生率约35%-55%（Colombo, N., et al., 2019）\u003C/li>\n        \u003Cli>靶向药联合治疗改善缓解率至40%-60%（Monk, B.J., et al., 2016）\u003C/li>\n      \u003C/ul>\n      \u003Cbr>\n      \u003Cstrong>参考文献（APA格式）：\u003C/strong>\u003Cbr>\n      \u003Cul>\n        \u003Cli>Monk, B.J., Sill, M.W., McMeekin, D.S., et al. (2016). Role of Targeted Therapies in Endometrial Cancer. \u003Cem>Gynecologic Oncology\u003C/em>, 143(3), 441-446.\u003C/li>\n        \u003Cli>Colombo, N., Creutzberg, C., Amant, F., et al. (2019). Chemotherapy in Endometrial Cancer. \u003Cem>Annals of Oncology\u003C/em>, 30(6), 1031–1040.\u003C/li>\u003C/ul>\u003C/div>\u003C/section>\n\n\u003Cstyle>\n.eknow-title {\n  background: linear-gradient(90deg,#abb8c3 0%,#e3eaf2 70%);\n  padding: 24px 30px 18px 30px;\n  text-align: center;\n  border-radius: 12px;\n  margin-bottom: 24px;\n}\n\n.eknow-intro {\n  font-size: 17px;\n  color: #333;\n  line-height: 1.7;\n  padding: 22px 18px 20px 18px;\n  background: linear-gradient(90deg,#f4f9fa 80%, #e6eef3 100%);\n  border-radius: 10px;\n  margin-bottom: 24px;\n}\n\n.eknow-section {\n  margin-bottom: 26px;\n}\n\n.eknow-section h2 {\n  font-size: 23px;\n  color: #30445a;\n  font-weight: 700;\n  margin-bottom: 0;\n  padding: 18px 20px 20px 22px;\n  border-radius: 10px 10px 0 0;\n  background: url(\"data:image/svg+xml,%3Csvg width='160' height='48' xmlns='http://www.w3.org/2000/svg'%3E%3Crect fill='%23e5effa' fill-opacity='0.82' x='0' y='0' width='160' height='48' rx='9'/%3E%3C/svg%3E\");\n}\n\n.eknow-bg-light {\n  background: linear-gradient(90deg, #f7f9fd 70%, #eef2f8 100%);\n}\n.eknow-bg-header {\n  font-size: 26px;\n  font-weight: bold;\n  background: url(\"data:image/svg+xml,%3Csvg width='32' height='32' xmlns='http://www.w3.org/2000/svg'%3E%3Cellipse fill='%23e0edff' cx='16' cy='16' rx='16' ry='14' fill-opacity='0.6'/%3E%3C/svg%3E\");\n  padding: 6px 12px;\n  border-radius: 50%;\n  margin-left: 8px;\n  vertical-align: middle;\n}\n.eknow-bg-block {\n  background: linear-gradient(90deg, #e3edf7 75%, #f7fafc 100%);\n  padding: 18px 20px;\n  border-radius: 0 0 14px 14px;\n  font-size: 16px;\n  color: #374a57;\n}\n.eknow-highlight {\n  background: #ffe7d6;\n  color: #d37b2b;\n  padding: 2px 8px;\n  border-radius: 6px;\n  font-weight: 500;\n}\n.eknow-section ul {\n  margin-left: 24px;\n  margin-bottom: 8px;\n  font-size: 15px;\n}\n.eknow-section li {\n  margin-bottom: 5px;\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" class=\"eknow-title\">\n  \u003Ch2 style=\"color: rgb(44, 62, 80); margin: 1.2em 0px",563,"2025-10-09 17:33:45","子宫内膜癌, 药物治疗, 化疗药物, 靶向药物, 免疫制剂, 用药指南, 副作用处理","本文提供子宫内膜癌分期2药品使用的详尽指南，包括化疗、靶向、免疫治疗的关键用法，帮助患者安全高效用药。","2025-10-24 00:00:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]